Norlab J197830LA User Manual

Emergency Contact: Chemtrec [phone]

Or Norco [phone]

1125 West Amity Road
Boise, ID 83705

[phone]

M A T E R I A L S A F E T Y D A T A S H E E T

Propane in Air 0.0001% to 1.5%

Identification

Product Name: Propane in Air 0.0001% to 1.5% Revision Date: 01/27/05
Chemical Name: Propane in Air Last Review Date: 02/20/07
Chemical Family: Gas Mixture
CAS Number: N/A
Common Names/Synonyms: N/A
MSDS Identification Code/Num ber: 2170
Prepared by: Quality Dept.

Composition, Information on Ingredients, Exposure Limits

Exposure Limits

Ingredient % Volume PEL-OSHA

Propane
Formula: C
CAS: 74-98-6
RTECS#: TX2275000
Air
Formula: N/A
CAS: N/A
RTECS#: N/A

1

Refer to individual state or provincial regulations, as applicable, for limits which may be more stringent than those listed here.

2

As stated in 29 CFR 1910, Subpart Z (revised July1, 1993)

3

As stated in the ACGIH 2006 Threshold Limit Values for Chemical Substances and Physical Agents.

OSHA Regulatory Status: This material is classified as hazardous under OSHA regulations.

3H8

1

:

2

TLV-ACGIH3 LD50 or LC

50

Route/Species

0.0001 to 1.5% 1000 PPM 1000 PPM Not available

98.5. to 99.9999% None Established Simple Asphyxiant Not Available

Hazards Identification

Emergency Overview:

Odorless, colorless, nonflammable gas. Inhalation of high concentrations of simple hydrocarbons can cause central nervous system
(CNS) depression and cardiac sensitization. Rapidly expanding gas may cause frostbite. Contents under pressure. Use and store
below 125
.

Route of Entry:

Health Effects:

Synergistic Effects
None reported

O

F (52OC)

Skin Contact

No

Exposure Limits

Teratogen

Yes

No

Skin Absorption

No

Eye Contact

No

Irritant

No

Reproductive Hazard

No

Inhalation

Yes

Ingestion

No

Sensitization

No

Mutagen

No

NorLab, Propane in Air 0.0001% to 1.5% Material Safety Data Sheet 2170 Page 2 of 5

Hazards Identification Continued

Carcinogenicity: NTP: No IARC: No OSHA: No

Eye Effects:

Contact with rapidly expanding gas near the point of release may cause frost bite.

Skin Effects:

Contact with rapidly expanding gas near the point of release may cause frost bite with redness, skin color change to gray or white and
blistering.

Ingestion Effects:

None known. Ingestion is unlikely as product is a gas at room temperature.

Inhalation Effects:

Product is relatively nontoxic. Inhalation of high propane concentrations may cause central nervous system depression with dizziness,
disorientation, in-coordination, nausea and narcosis. High concentrations may also cause cardiac sensitization resulting in irregular
heartbeat and may make the individual more susceptible to cardiac effects of substances such as epinephrine and adrenaline.

Medical Conditions Aggravated by Exposure: None known.

NFPA Hazard Codes HMIS Hazard Codes Ratings System

Health: 1 Health: 1 0: No Hazard
Flammability: 0 Flammability: 0 1: Slight Hazard
Instability: 0 Physical Hazard: 3 2: Moderate Hazard
3: Serious Hazard
4: Severe Hazard

Ratings were assigned in accordance with Co mpressed Gas Association (CGA) guidelines as publ i shed in CGA P-19-2004, CGA

Recommended Hazard Ratings for Compressed Ga ses, 2

nd

Edition.

First Aid Measures

Eyes:

None required for gas. If frostbite is suspected, flush eyes with cool water for 15 minutes and obtain immediate medical attention.

Skin:

None required for gas. For frostbite, immerse skin in lukewarm water. DO NOT USE HOT WATER. Obtain medical attention.

Ingestion:

None required.

Inhalation:

PROMPT MEDICAL ATTENTION IS MANDATORY IN ALL CASES OF OVEREXPOSURE. RESCUE PERSONNEL
SHOULD BE EQUIPPED WITH SELF-CONTAINED BREATHING APPARATUS. Conscious persons should be assisted to an
uncontaminated area and inhale fresh air. Quick removal from the contaminated area is most important. Unconscious persons should
be moved to an uncontaminated area, given assisted (artificial) respiration and supplemental oxygen. Further treatments should be
symptomatic and supportive.

Note to Physician: Monitor cardiac rhythm and treat arrhythmias as necessary. DO NOT administer stimulants such as epinephrine
or adrenaline.